Papadopoulou Maria V, Ji Ming, Bloomer William D
Evanston Northwestern Healthcare, Department of Radiation Medicine Evanston, IL 60201, USA.
Anticancer Res. 2006 Sep-Oct;26(5A):3253-8.
19F-labeled 2-nitroimidazoles bound to hypoxic cells in tumors are known to be useful probes for measuring hypoxia, since they can allow their non-invasive detection to be carried out by 19F nuclear magnetic resonance.
Seven different multifluorinated nitroimidazole-based compounds have been synthesized to furnish this aim: N,N-bis(m-trifluoromethylbenzyl)-3-(2-nitro-1-imidazolyl)propylamine hydrochloride (Bis-mTFN-1); N,N-bis(p-trifluoro-methylbenzyl)-3-(2-nitro-1-imidazolyl)propylamine hydrochloride (Bis-pTFN-1); N-3,5-di-trifluoro-methylbenzyl, 3-(2-nitro-1-imidazolyl)propylamine hydrochloride (DiCF3); N-(m-trifluoromethyl-benzyl)-3-(2-nitro-1-imidazolyl)-propylamine hydrochloride (mTFN-1); N-(p-trifluoromethylbenzyl)-3-(2-nitro-1-imidazolyl)propylamine hydrochloride (pTFN-1); N-(p-trifluoromethylbenzylcarbonyl)-3-(2-nitro-1-imidazolyl)propylamine (pTFA-1) and 5,6-dimethyl-4-[3-(2-nitro-1-imidazolyl)propylamino]-2-trifluoromethylpyrimidine hydrochloride (CF3PM). The compounds were studied in V79 cells in vitro, whereas selected compounds were tested for systemic toxicity in BALB/c mice.
With the exception of pTFA-1, all compounds were soluble in water or saline. All compounds were stable at room temperature as solids, or at 0-5 degrees C as aqueous solutions. Very good uptake were obtained in aerobic V79 cells with selected compounds. Thus, intracellular vs. extracellular concentration ratios (Ci/Ce) were increasing with input concentration up to 200. All compounds behaved as hypoxia-selective cytotoxins in V79 cells, in vitro, with selectivity ranging between 2.0 (DiCF3) to 15.5 (CF3PM). No lethality or body weight loss was observed with all tested compounds. Some signs of neurotoxicity were seen with bis-pTFN-1, mTFN-1 and pTFN-1 at the higher tested i.p. doses. No adverse effects were observed with CF3PM at any tested dose.
These results suggest that some of the above compounds could be utilized as 19F-MRS probes for measuring tumor-hypoxia, by accumulation and binding into the hypoxic regions of tumors.
已知与肿瘤中的缺氧细胞结合的19F标记的2-硝基咪唑是用于测量缺氧的有用探针,因为它们可以通过19F核磁共振进行非侵入性检测。
为实现这一目标,已合成了七种不同的多氟化硝基咪唑基化合物:N,N-双(间三氟甲基苄基)-3-(2-硝基-1-咪唑基)丙胺盐酸盐(双间TFN-1);N,N-双(对三氟甲基苄基)-3-(2-硝基-1-咪唑基)丙胺盐酸盐(双对TFN-1);N-3,5-二(三氟甲基)苄基,3-(2-硝基-1-咪唑基)丙胺盐酸盐(二CF3);N-(间三氟甲基苄基)-3-(2-硝基-1-咪唑基)丙胺盐酸盐(间TFN-1);N-(对三氟甲基苄基)-3-(2-硝基-1-咪唑基)丙胺盐酸盐(对TFN-1);N-(对三氟甲基苄基羰基)-3-(2-硝基-1-咪唑基)丙胺(对TFA-1)和5,6-二甲基-4-[3-(2-硝基-1-咪唑基)丙氨基]-2-三氟甲基嘧啶盐酸盐(CF3PM)。这些化合物在体外V79细胞中进行了研究,而选定的化合物在BALB/c小鼠中测试了全身毒性。
除对TFA-1外,所有化合物都可溶于水或盐水。所有化合物在室温下作为固体或在0-5摄氏度作为水溶液时都是稳定的。选定的化合物在有氧V79细胞中获得了非常好的摄取。因此,细胞内与细胞外浓度比(Ci/Ce)随着输入浓度增加到多达200而增加。所有化合物在体外V79细胞中表现为缺氧选择性细胞毒素,选择性范围在2.0(二CF3)至15.5(CF3PM)之间。所有测试的化合物均未观察到致死性或体重减轻。在较高的腹腔注射测试剂量下,双对TFN-1、间TFN-1和对TFN-1出现了一些神经毒性迹象。在任何测试剂量下,CF3PM均未观察到不良反应。
这些结果表明,上述一些化合物可通过在肿瘤缺氧区域的积累和结合,用作测量肿瘤缺氧的19F磁共振波谱探针。